{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:53:20Z","timestamp":1789516400940,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.atherosclerosis.2008.05.058","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T15:20:18Z","timestamp":1213370418000},"page":"59-66","source":"Crossref","is-referenced-by-count":21,"title":["Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317"],"prefix":"10.1016","volume":"203","author":[{"given":"Dacheng","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Hiipakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey S.","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutsung","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1358\/dnp.2004.17.1.829024","article-title":"Liver X receptors as potential therapeutic targets for multiple diseases","volume":"17","author":"Cao","year":"2004","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.289.5484.1524","article-title":"Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers","volume":"289","author":"Repa","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/01.ATV.0000218998.75963.02","article-title":"LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL","volume":"26","author":"Wang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib4","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/ATVBAHA.107.139592","article-title":"A pathway-dependent on ApoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells","volume":"27","author":"Yancey","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib6","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(02)03578-0","article-title":"T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice","volume":"536","author":"Terasaka","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.ATV.0000150044.84012.68","article-title":"Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists","volume":"25","author":"Levin","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib9","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib10","doi-asserted-by":"crossref","first-page":"34182","DOI":"10.1074\/jbc.M204887200","article-title":"Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles","volume":"277","author":"Grefhorst","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0002-9149(00)01127-9","article-title":"Evidence that triglycerides are an independent coronary heart disease risk factor","volume":"86","author":"Cullen","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/01.ATV.0000079793.58054.2E","article-title":"Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe","volume":"23","author":"Reardon","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib14","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1074\/jbc.M105711200","article-title":"Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements","volume":"277","author":"Yoshikawa","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(97)00325-6","article-title":"Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A","volume":"161","author":"Gao","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/01.ATV.21.6.1011","article-title":"Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice","volume":"21","author":"Reardon","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib18","doi-asserted-by":"crossref","first-page":"11896","DOI":"10.1073\/pnas.182199799","article-title":"Identification of macrophage liver X receptors as inhibitors of atherosclerosis","volume":"99","author":"Tangirala","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/ATVBAHA.107.143487","article-title":"Laminar shear stress regulates liver X receptor in vascular endothelial cells","volume":"28","author":"Zhu","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis: the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000150368.56660.4f","article-title":"Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries","volume":"95","author":"Blaschke","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2008.05.058_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.ATV.0000105054.43931.f0","article-title":"Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators","volume":"24","author":"VanderLaan","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008003894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008003894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T03:23:22Z","timestamp":1557631402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915008003894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0021915008003894"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.05.058","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}